Details for New Drug Application (NDA): 070942
✉ Email this page to a colleague
NDA 070942 describes TRIALODINE, which is a drug marketed by Quantum Pharmics and is included in one NDA. Additional details are available on the TRIALODINE profile page.
The generic ingredient in TRIALODINE is trazodone hydrochloride. There are fourteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the trazodone hydrochloride profile page.
The generic ingredient in TRIALODINE is trazodone hydrochloride. There are fourteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the trazodone hydrochloride profile page.
Summary for 070942
| Tradename: | TRIALODINE |
| Applicant: | Quantum Pharmics |
| Ingredient: | trazodone hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 070942
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Dec 1, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
